You are here

Licensing Opportunities

In 2019-2020 Cancer Research UK spent ~£450m on cancer research, from basic biology through to late-phase clinical trials. Resulting from this funding are a wide variety of oncology-focused projects available for licensing or collaboration, including novel chemotherapeutic and biological agents, diagnostic methodologies and enabling technologies. The projects range from new targets to therapies in pre-clinical development and phase 1/2 clinical studies.